Find out about all of the free NHS services available to support you as you go try to give up smoking.

Stay safe in the sun, including sunscreens, sunburn relief, heat exhaustion, eczema and moles. Summer holidays are great fun for children, but can bring risks. Find out more

Would you like loads of tips and help to make changes for a healthier future? As part of Change4Life, you will receive tons of helpful information, recipes, tools, tips, and games for the kids.

AP - Could your kitchen at home pass a restaurant inspection?

AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.

AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.

AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.

Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Reuters - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.

(MedPage Today) -- A second look at British registry data indicates that esophageal cancer may be more common after all in patients taking oral bisphosphonate drugs for long periods.

(MedPage Today) -- Age alone shouldn't deter appropriate oral anticoagulant use in elderly atrial fibrillation patients, according to a review.

(MedPage Today) -- At least half of children with severe, apparently treatment-resistant asthma can be successfully managed with conventional treatments using a thorough, multidisciplinary approach, researchers suggested.

STOCKHOLM (MedPage Today) -- Using two internal mammary arteries instead of one for CABG does not increase mortality, MI, stroke, or revascularization, one-year results of the multicenter randomized Arterial Revascularization Trial (ART) showed.

(MedPage Today) -- Nearly half of all Americans -- 48% -- took at least one prescription drug in a one-month period in 2007-2008, a four percentage point hike over a decade, researchers found.

WASHINGTON (MedPage Today) -- Employer-sponsored insurance will not only remain a cornerstone of the American healthcare system, but it will increase in prevalence in the post-healthcare reform environment, according to several researchers.

(MedPage Today) -- A two-hour molecular diagnostic test detected tuberculosis bacteria, including rifampin-resistant strains, with sensitivity and specificity well over 90%, researchers found.

(MedPage Today) -- While a physician's decision to start a child on growth hormone is usually consistent with evidence-based guidelines, continuation or intensification of therapy is strongly influenced by factors other than treatment response, according to a new survey.

STOCKHOLM (MedPage Today) -- An investigational potassium binder prevented hyperkalemia in at-risk patients with heart failure, a randomized, placebo-controlled trial showed.

(MedPage Today) -- Overweight patients with cardiovascular risks who took the weight-loss drug sibutramine had an increased likelihood of experiencing a cardiac event, a large randomized trial found.

Worldwide, H1N1 2009 virus transmission remains most intense in parts of India and in parts of the temperate southern hemisphere, particularly New Zealand and more recently in Australia.

The situation in New Zealand and India remains largely unchanged since the last update. Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

Influenza H1N1 (2009) virus transmission remains locally intense in parts of India and New Zealand.

The Emergency Committee held its ninth meeting by teleconference on 10 August 2010.

The world is now in the post-pandemic period. Based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus for some years to come. While the level of concern is now greatly diminished, vigilance on the part of national health authorities remains important. Such vigilance is especially critical in the immediate post-pandemic period, when the behaviour of the H1N1 (2009) virus as a seasonal virus cannot be reliably predicted.

As of 1 August 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18449 deaths.

As of 25 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18398 deaths.

As of 18 July 2010, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18366 deaths.

As part of regular monitoring of H1N1 pandemic influenza, the WHO is in close dialogue with public health experts in countries worldwide, specifically to determine whether H1N1 activity has returned to levels and patterns normally seen for seasonal flu.

As of 12 July, worldwide more than 214 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including over 18337deaths.